Profil
Steven Cha worked as Chief Medical Officer at Imugene Ltd. in 2022.
Dr. Cha worked as Chief Medical Officer at NKGen Operating Biotech, Inc. Dr. Cha worked as Senior Vice President-Clinical Research at Processa Pharmaceuticals, Inc. Dr. Cha completed undergraduate studies at the University of California San Diego and earned a doctorate from Tufts University School of Medicine.
Anciens postes connus de Steven Cha
| Sociétés | Poste | Fin |
|---|---|---|
| IMUGENE LIMITED | Directeur Technique/Scientifique/R&D | 01/06/2022 |
| PROCESSA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Directeur Technique/Scientifique/R&D | - |
Formation de Steven Cha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that manufactures natural killer cell therapies to treat cancer | Health Technology |
















